Related references
Note: Only part of the references are listed.Differential impact of mammalian target of rapamycin inhibition on CD4(+)CD25(+)Foxp3(+) regulatory T cells compared with conventional CD4(+) T cells
Robert Zeiser et al.
BLOOD (2008)
Vitamin a metabolites induce gut-homing FoxP3+ regulatory T cells
Seung G. Kang et al.
JOURNAL OF IMMUNOLOGY (2007)
Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer
Takafumi Nakamura et al.
CANCER SCIENCE (2007)
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation
Vu H. Nguyen et al.
BLOOD (2007)
Commensal bacteria exacerbate intestinal inflammation but are not essential for the development of murine ileitis
Giorgos Bamias et al.
JOURNAL OF IMMUNOLOGY (2007)
Regulatory T cells and T cell depletion: Role of immunosuppressive drugs
Marina Noris et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Selective survival of naturally occurring human CD4(+)CD25(+)Foxp3(+) regulatory T cells cultured with rapamycin
Laura Strauss et al.
JOURNAL OF IMMUNOLOGY (2007)
Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4(+) T cells, but enrich for antigen-specific Foxp3(+) T regulatory cells and promote organ transplant tolerance
Heth R. Turnquist et al.
JOURNAL OF IMMUNOLOGY (2007)
Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis
C. A. Keever-Taylor et al.
CYTOTHERAPY (2007)
Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients
Manuela Battaglia et al.
JOURNAL OF IMMUNOLOGY (2006)
The initial phase of graft-versus-host disease is associated with a decrease of CD4+CD25+ regulatory T cells in the peripheral blood of patients after allogeneic stem cell transplantation
M. Schneider et al.
CLINICAL AND LABORATORY HAEMATOLOGY (2006)
Role of naturally arising regulatory T cells in hematopoietic cell transplantation
Vu H. Nguyen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells
Danila Valmori et al.
JOURNAL OF IMMUNOLOGY (2006)
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production
Robert Zeiser et al.
BLOOD (2006)
Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD
K Rieger et al.
BLOOD (2006)
Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease
CA Wysocki et al.
BLOOD (2005)
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease
DR Couriel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
M Battaglia et al.
BLOOD (2005)
Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD
J Ermann et al.
BLOOD (2005)
Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation
C Cutler et al.
BONE MARROW TRANSPLANTATION (2004)
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation
JH Antin et al.
BLOOD (2003)
Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo
H Hackstein et al.
BLOOD (2003)
Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression
AM Woltman et al.
BLOOD (2003)
Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation
P Hoffmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells
H Hackstein et al.
BLOOD (2002)
Graft-versus-host disease prevention by rapamycin: Cellular mechanisms
BJ Chen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
Share Paper
